Biosimilars – a Different type of aHUS Drug
Biosimilar drugs are having an increased presence in conversations about the aHUS therapeutic drug landscape. Here's why they're of interest.
ADAMTS13 Testing: Fast 4 TMA Program
USTMA has partnered with Machaon Diagnostics to offer free ADAMTS13 testing through the new ‘Fast 4 TMA’ program for patients in…
Cause or effect aHUS/IBD
In crime programmes when someone lands on the ground from a great height the question asked is “were they pushed or…
SHUa ao redor do mundo: Brasil
Temos o prazer de oferecer mais uma em nossa série de “SHUa ao redor do mundo”, onde apresentamos as notícias e…
aHUS Awareness Day 2023 Theme – Capabilities & Possibilities
We’re pleased to announce the theme of ‘Capabilities & Possibilities’ as a focus to mark the 9th annual aHUS Awareness Day…
AHUS patients without kidney involvement- who are they
Diagnosing aHUS patients without kidney involvement has always seemed paradoxical. TMA can affect capillaries in all organs but the “u” in…
aHUS and the foetus
There are two involved in a pregnancy and birth the mother and the foetus /baby. The mother may or may not…
Later onset aHUS
We all want aHUS patients to survive to old age, but what about those whose aHUS onset is later in life.…
Atypical HUS in Brazil
Atypical HUS in Brazil - an interview with Pamela Notario of SHUa Brasil. (aHUS around the World: an aHUS Alliance Global Action series)
- Go to the previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- …
- 50
- Go to the next page